EVA Pharma’s roots stretch back over a hundred years.

Our History

Our experienced leadership team keeps us on track.

Meet our Leaders

EVA Pharma’s success is based on its dynamic team, Our people are our power.

Life at EVA Pharma

EVA Pharma Deepens Its Roots in China’s Thriving Biopharmaceutical Ecosystem with The Inauguration of Its Hangzhou OfficHangzhou, Cairo, 26 June 2025&nbsp;– &nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3735678-1&amp;h=1130473503&amp;u=http%3A%2F%2Fwww.evapharma.com%2F&amp;a=EVA+Pharma" target="_blank" rel="noopener"><span style="font-size: 11.0pt; font-family: 'IBM Plex Sans Arabic',sans-serif; mso-fareast-font-family: 'Times New Roman'; color: #007bff; border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;">EVA Pharma</a>, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East and Africa, has signed a cooperation agreement with the Chaming Qiantang Management Office in Hangzhou, strengthening its strategic global expansions and commitment to innovation, localization, and global collaboration in China.
EVA Pharma’s eighth global office, located in the vibrant city of Hangzhou, was established following the signing of the agreement. Under this cooperation, EVA Pharma will leverage the advantageous resources of Qiantang District’s biopharmaceutical industry. The new branch will focus on research and development and strategic supply operations in the field of pharmaceuticals, vaccines, and biologics.
“By anchoring our presence in leading innovation hubs like Hangzhou’s Biopharma Town, EVA Pharma is shaping a future where collaboration drives resilience.” said Riad Armanious, CEO of EVA Pharma. “In Qiantang District, we bring our experience in localizing production and advancing innovation to build a network that makes access to high-quality healthcare faster, smarter, and more equitable, from China to the Middle East and beyond.”
With significant national investment, China innovation ecosystem has made it a global leader in Cell and Gene Therapy (CGT) and Hangzhou is at the forefront. Home to cutting-edge academic centers, world-class incubators, and specialized GMP platforms, BioPharma Town has attracted a growing number of companies focused on mRNA vaccines, CAR-T therapy, gene editing, and regenerative medicine. 
&nbsp;Through this partnership, EVA Pharma aims to leverage local capabilities in Hangzhou BioPharma Town while contributing its own R&amp;D expertise, analytical development workflows, and regional regulatory knowledge to explore joint projects in vaccine technology, mRNA applications, and therapeutic biologics. 
 End of Press Release

thumbnail_WhatsApp Image 2025-06-26 at 21.12.41.jpeg

WhatsApp Image 2025-06-26 at 21.12.41.jpeg

EVA Pharma and BioPharma Town - Qiantang District, Hangzhou Sign a Strategic Cooperation Agreement

EVA Pharma Deepens Its Roots in China’s Thriving Biopharmaceutical Ecosystem with The Inauguration of Its Hangzhou Office



EVA Pharma and BioPharma Town - Qiantang District, Hangzhou Sign a Strategic Cooperation Agreement

26 June, 2025

EVA Pharma and BioPharma Town - Qiantang District, Hangzhou Sign a Strategic Cooperation Agreement

26 June, 2025

Find out more about EVA Pharma

EVA Pharma’s roots stretch back over a hundred years.

Our experienced leadership team keeps us on track.

EVA Pharma’s success is based on its dynamic team, Our people are our power.